Stay updated on Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Sign up to get notified when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The two screenshots depict the same study details page with no substantive differences in core content, such as the study overview, eligibility criteria, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T20:40:55.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    32 days ago
    Change Detected
    Summary
    Major update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.
    Difference
    3%
    Check dated 2025-10-06T05:07:57.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    Update to version v3.1.0; removal of several MedlinePlus topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and archival of v3.0.2.
    Difference
    0.4%
    Check dated 2025-09-29T02:57:32.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page revision was updated from v3.0.1 to v3.0.2, and the 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T18:54:20.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-07T13:35:14.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of terms related to drug safety and counterfeit drugs. Notably, the previous version's references to certain drug names and conditions have been removed.
    Difference
    7%
    Check dated 2025-08-31T11:28:47.000Z thumbnail image

Stay in the know with updates to Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Effect of Nintedanib on ECM Biomarkers in IPF Clinical Trial page.